|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.15 USD | -0.95% |
|
+6.68% | -13.54% |
| Apr. 15 | Sector Update: Health Care Stocks Gain Monday Afternoon | MT |
| Apr. 15 | Global markets live: Goldman Sachs, Apple, Salesforce, Boeing Tesla... |  |
June 14 (Reuters) - Novavax Inc said on Monday vaccine efficacy appeared to be preserved in those receiving an approved influenza vaccine along with its COVID-19 vaccine candidate compared to those vaccinated with the COVID-19 vaccine candidate alone. (Reporting by Amruta Khandekar)
| 1st Jan change | Capi. | |
|---|---|---|
| -13.54% | 586M | |
| +4.09% | 43.43B | |
| +47.81% | 41.69B | |
| +9.45% | 41.31B | |
| -10.92% | 27.14B | |
| +9.32% | 25.28B | |
| -24.87% | 18.47B | |
| +29.70% | 12.59B | |
| +1.28% | 12.33B | |
| +7.78% | 11.03B |
NOVAVAX, INC. 
